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Abstract
BACKGROUND/OBJECTIVES—It has been recognized that certain long-chain
polyunsaturated fatty acids (LC-PUFAs) are involved in inflammation and its resolution. It has
also been shown that ethnicity may be a factor in affecting systemic inflammation, and limited
evidence suggests it may influence plasma LC-PUFA composition. Given the links among these
three factors, we aim to determine ethnicity-based differences in plasma LC-PUFA composition
among White, Black, Hispanic and Chinese participants, and whether such differences contribute
to variations in markers of inflammation and endothelial activation in a sub-cohort of the Multi-
Ethnic Study of Atherosclerosis (MESA).
SUBJECTS/METHODS—Plasma phospholipid LC-PUFAs levels (%) were determined in 2848
MESA participants using gas chromatography-flame ionization detection. Enzyme immunoassays
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determined inflammatory markers levels for high-sensitivity C-reactive protein (n =2848),
interleukin-6 (n =2796), soluble tumor necrosis factor-α receptor type 1 (n =998), and endothelial
activation markers soluble intercellular adhesion molecule-1 (n =1192) and soluble E-selectin (n
=998).
The modifying influence of ethnicity was tested by linear regression analysis.
RESULTS—Chinese adults were found to have the highest mean levels of plasma
eicosapentaenoic acid (EPA, 1.24%) and docosahexaenoic acid (DHA, 4.95%), and the lowest
mean levels of γ-linolenic (0.10%), dihomo-γ-linolenic (DGLA, 2.96%) and arachidonic (10.72%)
acids compared with the other ethnicities (all P≤0.01). In contrast, Hispanics had the lowest mean
levels of plasma EPA (0.70%) and DHA (3.49%), and the highest levels of DGLA (3.59%; all
P≤0.01). Significant differences in EPA and DHA among ethnicities were attenuated following
adjustment for dietary non-fried fish and fish oil supplementation. Ethnicity did not modify the
associations of LC-PUFAs with markers of inflammation or endothelial activation (all
Pinteraction>0.05).
CONCLUSIONS—The absence of a modifying effect of ethnicity indicates that the putative
benefits of LC-PUFAs with respect to inflammation are pan-ethnic. Future longitudinal studies
may elucidate the origin(s) of ethnicity-based differences in LC-PUFA composition and whether
certain patterns, that is, high plasma levels of DGLA and low levels of EPA/DHA, contribute to
inflammation-associated health outcomes.
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INTRODUCTION
Dietary intake of long-chain polyunsaturated fatty acids (LC-PUFAs) has gained recent
media attention, yet their benefits were recognized decades ago in studies of Greenland
Inuit. High intakes of the ‘fish oil’ omega-3 (n-3) LC-PUFAs eicosapentaenoic acid (EPA)
and docosahexaenoic acid (DHA) were found to correspond with low incidences of
cardiovascular disease (CVD) and thrombosis.1 More recent studies have extended these
findings to the omega-6 (n-6) LC-PUFAs–revealing that arachidonic acid (AA) and linoleic
acid (LA) are associated with lower incidence of CVD,2 – 5 although results are
inconsistent.6 – 8 The mechanisms by which they may affect CVD are not entirely known,
but LC-PUFAs have been shown to associate with lower levels of inflammatory markers,9
suppress pro-inflammatory cytokine production10 and reduce hallmarks of an atherogenic
lipid phenotype–high levels of triglycerides and small dense low-density lipoprotein
particles.11,12 Even more recently, LC-PUFAs have been shown to metabolize into
compounds that actively resolve the inflammatory response,13 – 15 that is, have ‘pro-
resolving’ properties. Given that CVD has a strong inflammatory component, the health
benefits of LC-PUFA intake may partially be a function of such anti-inflammatory, pro-
resolving properties.
Clearly, LC-PUFA composition is not the only factor that affects an inflammatory
phenotype or disease risk. A host of additional lifestyle factors such as physical activity
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levels and obesity, as well as non-lifestyle factors such as ethnicity, have been shown to
influence inflammation. Indeed, certain ethnicities appear to be more predisposed toward
chronic inflammation than others–for example, Black adults have been shown to have higher
levels of inflammatory markers compared with Hispanics, Whites or Asians in a number of
studies,16 – 19 including the Multi-Ethnic Study of Atherosclerosis (MESA).20,21 Further,
some ethnic groups have been shown to have a higher prevalence of diseases that have been
associated with inflammation–for example, higher prevalences of diabetes, hypertension and
increased left ventricular mass have been noted in Blacks compared with Hispanics and
Whites, with the lowest prevalence among Asians.22 – 24 LC-PUFAs are known to affect the
inflammatory response and are associated with inflammation in relatively homogenous
study populations;25,26 thus, a greater understanding of LC-PUFA variation among a
heterogeneous study population may provide insight into the development of inflammatory
conditions such as CVD.
Using a large multi-ethnic cohort of MESA participants, the present study aims to determine
differences in plasma LC-PUFA compositions, as well as inflammatory and endothelial
activation markers among Black, White, Hispanic and Chinese–American participants.
Further, the study aims to determine whether ethnicity modifies the relations of plasma LC-
PUFAs with inflammatory and endothelial activation markers.
MATERIALS AND METHODS
Population
The primary aim of MESA is to investigate the development and progression of subclinical
CVD. The study design and methods have been described,27 and information about the
MESA protocol is available online (www.mesa-nhlbi.org). Briefly, 6814 men and women
between the ages of 45 and 84 years without clinical evidence of CVD were recruited from
six communities in the United States (Baltimore, MD; Chicago, IL; Forsyth County, NC;
Los Angeles County, CA; New York, NY; and St Paul, MN). During recruitment, questions
on ethnicity were asked based on the United States 2000 census questionnaire. Subjects who
self-reported their ethnic group as White or White, Black or African American, Chinese, or
Spanish/Hispanic/Latino were potentially eligible. Institutional Review Board approval was
obtained at all MESA sites, and all participants gave informed consent. Recruitment and
baseline examinations began in July 2000 and were conducted over a 24-month period. The
present cohort was composed of 2848 MESA participants who gave informed consent
(MESA Genetics Candidate Gene Evaluation Cohort); each race was represented relatively
equally, African American (n =703), Asian (of Chinese descent n =712), Hispanic (n =709)
and White (n =722) participants.
Measurements
Questionnaire information was obtained regarding age, sex, ethnicity, education and lifestyle
factors including smoking status, physical activity and dietary intake. Physical activity is
represented by the sum of intentional exercise in metabolic equivalent-min/week, including
walking for exercise, sports, dancing and conditioning activities. Usual dietary intake over
the previous year was assessed through a self-administered, 120-item food frequency
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questionnaire in which responses were given as never/rare to frequently (≥2 times per day),
and serving sizes were listed as small, medium or large. Height and weight were measured
according to standard procedures.27 Fasting blood was drawn and serum and EDTA-
anticoagulant tubes were collected and processed using a standardized protocol.27 The
serum and plasma samples were aliquoted and stored at −70 °C until time of use.
Plasma fatty acid profile—Phospholipid fatty acids were extracted from EDTA plasma
(n =2848) using the method previously described by Cao et al.28 In brief, lipids were
extracted from the plasma using a chloroform/methanol extraction method, and the
cholesterol esters, triglyceride, phospholipids and free fatty acids were separated by thin
layer chromatography. Fatty acids from the phospholipids were derivatized to methyl esters
and detected by gas chromatography flame ionization. The fatty acids detected were
expressed as a percent of total fatty acids. The following representative correlation values
were obtained from intra-laboratory quality control (n =20): LA 2.6%; α-LA, 2.4%; AA,
2.4%; EPA, 3.3%; DPA, 2.9% and DHA, 2.7%.
Analysis of inflammatory markers/cytokines adhesion/endothelial activation markers
High-sensitivity C-reactive protein (hsCRP) was measured (n =2848) on a BNII
nephelometer (N High-Sensitivity CRP; Dade Behring Inc., Deerfield, IL, USA) using a
particle-enhanced immuno-nephelometric assay. Interleukin-6 (IL-6; n =2796), tumor
necrosis factor-α soluble receptor 1 (sTNF-R1; n =998), soluble intercellular adhesion
molecule-1 (sICAM-1; n =1192) and soluble E-selectin (sE-selectin; n =998) were measured
using the quantitative sandwich enzyme immunoassay technique of enzyme-linked
immunosorbent assay assays (Quantikine HS Human IL-6 Immunoassay, Quantikine
Human sTNF-RI Immunoassay, Parameter Human sICAM-1 Immunoassay, Parameter
Human sE-Selectin Immunoassay, respectively; R&D Systems, Minneapolis, MN, USA).
Importantly, significant differences in sICAM-1 were not evaluated in all ethnic groups, as a
previous report29 indicates that a common single-nucleotide polymorphism of sICAM-1 in
Black individuals results in an underestimation of sICAM-1.
Statistical analysis
All analyses were conducted using SAS (version 9.2, SAS Institute, Inc., Cary, NC, USA).
Body mass index was calculated as weight in kg divided by height in (m) squared. Baseline
characteristics are presented as means (s.d.) for continuous variables and frequencies (%) for
categorical variables and stratified by ethnic group. Levels of biomarkers with skewed
distributions were log-transformed before analysis, and results were back-transformed and
presented as geometric means. Generalized linear regression analysis further evaluated
levels of biomarkers and plasma phospholipid fatty acids according to the ethnic group,
adjusting for potential confounding factors known to affect these measures, including age,
gender, field center, socioeconomic status with highest education level attained, smoking,
physical activity, energy intake, non-fried fish intake, body mass index, high-density
lipoprotein –cholesterol, low-density lipoprotein– cholesterol, triglycerides and diagnosed
diabetes. MESA dietary data for fish intake are more fully detailed by Chung et al.30
Interaction terms were included in the models to determine whether ethnic group modified
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the association between plasma phospholipid fatty acids and biomarkers adjusting for
potential confounding factors. Statistical tests were considered significant at P≤0.01.
RESULTS
Baseline characteristics are shown in Table 1. Overall, the cohort was made up of 25.4%
White, 24.7% Black, 24.9% Hispanic and 25.0% Chinese participants. Average age was
62.1±10.2 years, over 50% was female, and the majority of adults had greater than a high
school education.
Markers of inflammation and endothelial activation were significantly different among
ethnicities after adjusting for confounding factors including body mass index (Table 2).
Generally, Chinese adults had the lowest mean levels of these markers compared with those
of other ethnicities, except for sE-selectin. No other differences were observed among other
ethnic groups for inflammatory markers hsCRP or IL-6. sE-selectin levels did not differ
significantly among study participants. Differences in sICAM-1 in Black individuals could
not be evaluated and is discussed in the limitations section.
Significant differences in plasma phospholipid LC-PUFA composition were found across
ethnicities after adjusting for potential confounding factors (Table 3). Chinese adults had the
highest relative levels of plasma n-3 fatty acids EPA and DHA, as well as n-6 LA levels, but
the lowest levels of GLA (18:3, n-6), dihomo-γ-linolenic (DGLA; 20:3, n-6) and AA (20:4,
n-6) compared with other ethnicities. To evaluate whether differences in EPA and DHA
levels were primarily a function of non-fried fish intake and fish oil supplementation, these
covariates were included in an additional statistical model. Differences in plasma EPA levels
were found to be dependent on non-fried fish intake and fish oil supplementation, as no
significant race differences were observed following adjustment. Likewise, differences in
DHA levels were attenuated, and only found to be higher in Chinese compared with
Hispanics (P =0.02) after adjustment for non-fried fish intake and fish oil supplementation.
Hispanics initially showed the lowest levels of plasma EPA and DHA, but again no
statistical significance was shown following further adjustment for confounding factors.
Notably, the highest levels of DGLA were found in Hispanic participants, whereas the
highest levels of plasma GLA (18:3, n-6) were observed among White participants. Finally,
Black participants had the highest levels of plasma AA, but, along with Chinese adults, the
lowest levels of GLA (18:3, n-6) and DGLA (20:3, n-6). No significant differences were
observed in plasma α-LA (18:3, n-3).
Though significant associations were observed between phospholipid LC-PUFAs and
biomarkers (Table 4), ethnicity did not modify these associations (all Pinteraction>0.05). The
highest levels of GLA and DGLA corresponded with the highest levels of IL-6, and either
sTNFR-1 or hsCRP. Levels of GLA and DGLA were also positively associated with higher
concentrations of sE-selectin and sICAM-1, respectively. In contrast, significant inverse
associations were found between IL-6 and EPA, as well as DHA. In addition, EPA was
inversely associated with sTNF-R1, and plasma levels of the n-6 fatty acid LA were
inversely associated with hsCRP and sE-selectin.
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In this cross-sectional analysis, significant differences among ethnicities were observed in
plasma phospholipid LC-PUFA composition, as well as markers of inflammation and
endothelial activation. Contrary to our hypothesis, the associations between LC-PUFAs and
markers of inflammation and endothelial activation were not modified by ethnicity.
Plasma phospholipid LC-PUFA composition differs among ethnicities
The current study is the largest to examine plasma LC-PUFA composition of White, Black,
Hispanic and Chinese adults, though previous investigators have reported differences in
plasma LC-PUFAs in other ethnically diverse populations.31 – 33 Nogi et al.32 observed that
Japanese individuals had three-fold higher plasma EPA levels as well as two-fold higher
plasma DHA levels compared with Mongolian individuals, with levels for Korean
individuals falling between them. Van Eijsden et al.33 found significant differences in n-3
and n-6 LC-PUFAs among Dutch, Turkish, Moroccan, Surinamese, Ghanaian and Antilean
participants. Finally, Young et al.31 found that Canadian Inuit had significantly increased
levels of plasma phospholipid EPA and remarkably lower levels of DGLA, AA and total n-6
fatty acids compared with non-Inuit in the same region. Notably, the variations in fatty acid
composition were found to be independent of diet, despite the large inter-group variation in
fish and marine fatty acid dietary intakes. In contrast, no differences in LC-PUFA levels
were observed between Whites and Hispanics in a study by Haffner et al.,34 though limited
sample size may have contributed to the null findings. The origin(s) for variations in LC-
PUFA composition among ethnicities is not entirely clear, but a number of genetic and
environmental factors have been found.
It is currently known that plasma phospholipid and membrane fatty acids partially reflect
dietary intake, particularly the fatty acids associated with fish (EPA and DHA).30,35
Differences in fish consumption have been noted among ethnicities in the MESA
population,36,37 and EPA + DHA levels were found to correlate with non-fried fish
consumption in a sub-cohort of MESA participants.30 Adjustments were therefore made in
our statistical models for non-fried fish intake and fish oil supplementation. Following this
adjustment, plasma EPA and DHA levels were not significantly different among ethnicities,
with one notable exception: plasma DHA levels were higher in Chinese compared with
Hispanic participants. Though fish/fish oil intake largely accounted for the differences in
plasma EPA and DHA among ethnicities, it is likely that other factors such as fatty acid
bioavailability and/or metabolism contribute to variations in plasma n-6 fatty acid and DHA
levels among ethnic groups, in agreement with Chung et al.30
The metabolism of DHA and n-6 LC-PUFAs involves a multitude of pathways and
enzymes, the Δ5 and Δ6 desaturases and elongases among them.38 In addition, LC-PUFAs
are substrates for eicosanoid generation, including the prostaglandins, prostacyclins,
leukotrienes and lipoxins, as well as the newly discovered ‘non-classic’ eicosanoids
including the resolvins, protectins and maresins. Evidence has suggested that gene
polymorphisms of these metabolic enzymes may contribute to differences in LC-PUFA
composition.39 – 41 Observed in the InCHIANTI study, cluster polymorphisms encoding Δ6
desaturase (FADS gene) partially accounted for the variance in plasma AA levels,39 and the
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ELOVL2 gene was found to be involved in the homeostasis of longer chain n-3 fatty acids.
The Genetics of Coronary Artery Disease in Alaska Natives study revealed that genetic
variations in APOJ, LPL and TNFRSF10B genes significantly influenced plasma fatty acid
distribution.40 Ultimately, future MESA studies may provide evidence as to whether such
distinct gene polymorphisms contribute to the differences in LC-PUFA composition
observed here.
Inflammatory and endothelial activation markers differ across ethnicities
In agreement with Stowe et al.,16 but in contrast to other studies,18,21 we did not observe
higher levels of hsCRP in Blacks compared with Whites or Hispanics after adjusting for
confounders. However, we did find that hsCRP was lower in Chinese compared with
Whites, Blacks and Hispanics, as found by a number of previous studies.18,19,21 In general,
Chinese participants showed the lowest levels of endothelial activation and inflammatory
markers among the ethnic groups studied here. As high levels of these biomarkers are
widely considered risk factors for CVD, previous findings and ours may partially explain the
lower incidence of CVD in individuals of Chinese or Asian descent.42
Strengths and limitations
The present study avoided the inherent problems of relying on dietary questionnaires by
directly measuring plasma phospholipid levels of fatty acids. Further, plasma phospholipid
fatty acids are considered a reflection of membrane fatty acids–thus, observed differences
are inclusive of the multitude of metabolic processes associated with fatty acids, which is
not the case with dietary fatty acid intake data.
The cross-sectional study design limits our ability to determine the temporal relation
between levels of LC-PUFAs and selected biomarkers. Additionally, plasma fatty acids,
sTNF-R1, IL-6, sICAM-1 and sE-selectin were only measured in a subset of individuals
enrolled in the MESA study; consequently, the study may have been underpowered to find
true associations in some instances. Finally, we adjusted for several confounding factors in
our statistical model; however, it is possible that residual confounders remain.
CONCLUSIONS
It was found that the inverse associations of certain n-3 and n-6 LC-PUFAs with
inflammatory/endothelial markers are not based on ethnicity, and benefits of these LC-
PUFAs would therefore be expected to be pan-ethnic. Dietary fish and fish oil
supplementation largely accounted for differences in phospholipid EPA +DHA levels
among ethnicities. Future studies examining gene variants in fatty acid metabolism may
provide the basis for the observed race/ethnicity based differences in plasma DHA and n-6
LC-PUFA composition. Future longitudinal studies will better define the consequences of
LC-PUFA composition variation and whether certain patterns, that is, high levels of DGLA
and low levels of EPA/DHA found here, contribute to long-term chronic inflammation and
associated health outcomes in MESA participants.
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Table 3
Mean levelsa of individual plasma phospholipid fatty acids (%) by ethnic groups: MESA, n =2846
Fatty acidb (%) White (n =722) Black (n =703) Hispanic (n =709) Chinese (n =712)
LA 18:2, n-6 20.93 bch 19.95 chw 21.97 bcw 22.95 bhw
ALA 18:3, n-3 0.18 0.17 0.18 0.17
GLA 18:3, n-6 0.120 bch 0.107 cw 0.107 cw 0.097 bhw
DGLA 20:3, n-6 3.39 bc 3.05 hw 3.48 bc 2.92 hw
AA 20:4, n-6 12.04 bch 13.53 chw 11.56 bcw 10.84 bhw
EPA 20:5, n-3
Model 1a 0.99 ch 0.95 ch 0.75 bcw 1.20 bhw
Model 2c 1.68 1.06 1.12 1.81
DHA 22:6, n-3
Model 1a 3.83 bch 4.51 chw 3.58 bcw 4.95 bhw
Model 2c 4.97 5.35 4.37 c 5.56 h
Abbreviations: AA, arachidonic acid; ALA, α-linolenic acid; b, Black; c, Chinese; DGLA, dihomo-γ-linolenic acid; DHA, docosahexaenoic acid;
EPA, eicosapentaenoic acid; GLA, γ-linolenic acid; h, Hispanic; HDL, high-density lipoprotein; LA, linoleic acid; LDL, low-density lipoprotein;
MESA, Multi-Ethnic Study of Atherosclerosis. Difference observed between groups (Pdiff≤0.01): b, c, h, w.
a
Adjusted for age, sex, education, field center, smoking, energy intake, physical activity, BMI, HDL, LDL, triglycerides and diabetes.
b
LA, ALA, GLA, DGLA, AA, EPA, DHA.
c
EPA and DHA levels were further adjusted for non-fried fish intake and fish oil supplements.
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